406 related articles for article (PubMed ID: 16267267)
1. Different Plk1 functions show distinct dependencies on Polo-Box domain-mediated targeting.
Hanisch A; Wehner A; Nigg EA; Silljé HH
Mol Biol Cell; 2006 Jan; 17(1):448-59. PubMed ID: 16267267
[TBL] [Abstract][Full Text] [Related]
2. Deficiency in chromosome congression by the inhibition of Plk1 polo box domain-dependent recognition.
Watanabe N; Sekine T; Takagi M; Iwasaki J; Imamoto N; Kawasaki H; Osada H
J Biol Chem; 2009 Jan; 284(4):2344-53. PubMed ID: 19033445
[TBL] [Abstract][Full Text] [Related]
3. High mitotic activity of Polo-like kinase 1 is required for chromosome segregation and genomic integrity in human epithelial cells.
Lera RF; Burkard ME
J Biol Chem; 2012 Dec; 287(51):42812-25. PubMed ID: 23105120
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of mammalian polo-like kinase 1 (Plk1) localization: self- versus non-self-priming.
Lee KS; Park JE; Kang YH; Zimmerman W; Soung NK; Seong YS; Kwak SJ; Erikson RL
Cell Cycle; 2008 Jan; 7(2):141-5. PubMed ID: 18216497
[TBL] [Abstract][Full Text] [Related]
5. Molecular and structural basis of polo-like kinase 1 substrate recognition: Implications in centrosomal localization.
García-Alvarez B; de Cárcer G; Ibañez S; Bragado-Nilsson E; Montoya G
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3107-12. PubMed ID: 17307877
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1.
Yun SM; Moulaei T; Lim D; Bang JK; Park JE; Shenoy SR; Liu F; Kang YH; Liao C; Soung NK; Lee S; Yoon DY; Lim Y; Lee DH; Otaka A; Appella E; McMahon JB; Nicklaus MC; Burke TR; Yaffe MB; Wlodawer A; Lee KS
Nat Struct Mol Biol; 2009 Aug; 16(8):876-82. PubMed ID: 19597481
[TBL] [Abstract][Full Text] [Related]
7. Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivo.
Yuan J; Sanhaji M; Krämer A; Reindl W; Hofmann M; Kreis NN; Zimmer B; Berg T; Strebhardt K
Am J Pathol; 2011 Oct; 179(4):2091-9. PubMed ID: 21839059
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the Allosteric Communication between the Polo-Box Domain and the Catalytic Domain in Plk1 by Small Compounds.
Raab M; Sanhaji M; Pietsch L; Béquignon I; Herbrand AK; Süß E; Gande SL; Caspar B; Kudlinzki D; Saxena K; Sreeramulu S; Schwalbe H; Strebhardt K; Biondi RM
ACS Chem Biol; 2018 Aug; 13(8):1921-1931. PubMed ID: 29927572
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitylation-dependent localization of PLK1 in mitosis.
Beck J; Maerki S; Posch M; Metzger T; Persaud A; Scheel H; Hofmann K; Rotin D; Pedrioli P; Swedlow JR; Peter M; Sumara I
Nat Cell Biol; 2013 Apr; 15(4):430-9. PubMed ID: 23455478
[TBL] [Abstract][Full Text] [Related]
10. Polo-box domains confer target specificity to the Polo-like kinase family.
van de Weerdt BC; Littler DR; Klompmaker R; Huseinovic A; Fish A; Perrakis A; Medema RH
Biochim Biophys Acta; 2008 Jun; 1783(6):1015-22. PubMed ID: 18359294
[TBL] [Abstract][Full Text] [Related]
11. Self-regulated Plk1 recruitment to kinetochores by the Plk1-PBIP1 interaction is critical for proper chromosome segregation.
Kang YH; Park JE; Yu LR; Soung NK; Yun SM; Bang JK; Seong YS; Yu H; Garfield S; Veenstra TD; Lee KS
Mol Cell; 2006 Nov; 24(3):409-22. PubMed ID: 17081991
[TBL] [Abstract][Full Text] [Related]
12. Plk1 activation by Ste20-like kinase (Slk) phosphorylation and polo-box phosphopeptide binding assayed with the substrate translationally controlled tumor protein (TCTP).
Johnson TM; Antrobus R; Johnson LN
Biochemistry; 2008 Mar; 47(12):3688-96. PubMed ID: 18298087
[TBL] [Abstract][Full Text] [Related]
13. Identification of green tea catechins as potent inhibitors of the polo-box domain of polo-like kinase 1.
Shan HM; Shi Y; Quan J
ChemMedChem; 2015 Jan; 10(1):158-63. PubMed ID: 25196850
[TBL] [Abstract][Full Text] [Related]
14. Selective blockade of cancer cell proliferation and anchorage-independent growth by Plk1 activity-dependent suicidal inhibition of its polo-box domain.
Park JE; Kim TS; Kim BY; Lee KS
Cell Cycle; 2015; 14(22):3624-34. PubMed ID: 26513691
[TBL] [Abstract][Full Text] [Related]
15. The Functional Significance of Posttranslational Modifications on Polo-Like Kinase 1 Revealed by Chemical Genetic Complementation.
Lasek AL; McPherson BM; Trueman NG; Burkard ME
PLoS One; 2016; 11(2):e0150225. PubMed ID: 26919439
[TBL] [Abstract][Full Text] [Related]
16. A cryptic hydrophobic pocket in the polo-box domain of the polo-like kinase PLK1 regulates substrate recognition and mitotic chromosome segregation.
Sharma P; Mahen R; Rossmann M; Stokes JE; Hardwick B; Huggins DJ; Emery A; Kunciw DL; Hyvönen M; Spring DR; McKenzie GJ; Venkitaraman AR
Sci Rep; 2019 Nov; 9(1):15930. PubMed ID: 31685831
[TBL] [Abstract][Full Text] [Related]
17. HSP70 colocalizes with PLK1 at the centrosome and disturbs spindle dynamics in cells arrested in mitosis by arsenic trioxide.
Chen YJ; Lai KC; Kuo HH; Chow LP; Yih LH; Lee TC
Arch Toxicol; 2014 Sep; 88(9):1711-23. PubMed ID: 24623308
[TBL] [Abstract][Full Text] [Related]
18. Rational Molecular Design of Potent PLK1 PBD Domain-binding Phosphopeptides Using Preferential Amino Acid Building Blocks.
Mao XL; Wang KF; Zhu F; Pan ZH; Wu GM; Zhu HY
Chem Biodivers; 2016 Aug; 13(8):1103-10. PubMed ID: 27450535
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential Plk1 targets in a cell-cycle specific proteome through structural dynamics of kinase and Polo box-mediated interactions.
Bibi N; Parveen Z; Rashid S
PLoS One; 2013; 8(8):e70843. PubMed ID: 23967120
[TBL] [Abstract][Full Text] [Related]
20. Targeting subcellular localization through the polo-box domain: non-ATP competitive inhibitors recapitulate a PLK1 phenotype.
McInnes C; Estes K; Baxter M; Yang Z; Farag DB; Johnston P; Lazo JS; Wang J; Wyatt MD
Mol Cancer Ther; 2012 Aug; 11(8):1683-92. PubMed ID: 22848093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]